Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Walker

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Blood Advances|April 14, 2022
Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101Ellen K Ritchie, Heidi D Klepin, Elizabeth Storrick, et al.
British Paramedic Journal|March 11, 2026
Ambulance service demand from prisons: a service evaluationCath Hodson, Laura-Sarona Fox, Richard Pilbery, et al.
Heart (British Cardiac Society)|January 14, 2019
Diagnostic accuracy of the T-MACS decision aid with a contemporary point-of-care troponin assayRichard Body, Malak Almashali, Niall Morris, et al.
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.
Journal of Telemedicine and Telecare|November 2, 2016
Exploring the benefits of a stroke telemedicine programme: An organisational and societal perspectiveKathleen L Bagot, Christopher F Bladin, Michelle Vu, et al.
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
Annals of Hematology|November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbiditiesNathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
The Lancet Regional Health. Europe|April 18, 2025
Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialMichael A Smyth, Hannah Noordali, Kath Starr, et al.
Oncotarget|March 9, 2018
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemiaBhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Blood Advances|April 14, 2022
Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101Ellen K Ritchie, Heidi D Klepin, Elizabeth Storrick, et al.
British Paramedic Journal|March 11, 2026
Ambulance service demand from prisons: a service evaluationCath Hodson, Laura-Sarona Fox, Richard Pilbery, et al.
Heart (British Cardiac Society)|January 14, 2019
Diagnostic accuracy of the T-MACS decision aid with a contemporary point-of-care troponin assayRichard Body, Malak Almashali, Niall Morris, et al.
Leukemia Research|February 8, 2025
Serum hypoalbuminemia is an independent prognostic factor in Chronic Myelomonocytic Leukemia (CMML)Zena Komrokji, Najla Al Ali, Zhuoer Xie, et al.
Journal of Telemedicine and Telecare|November 2, 2016
Exploring the benefits of a stroke telemedicine programme: An organisational and societal perspectiveKathleen L Bagot, Christopher F Bladin, Michelle Vu, et al.
Blood|June 9, 2012
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemiaParvathi Ranganathan, Xueyan Yu, Caroline Na, et al.
Annals of Hematology|November 29, 2023
Young patients with myelofibrosis have distinct clinicomolecular features, favorable prognosis, and commonly exhibit inflammatory comorbiditiesNathan P Horvat, Enas F Abdallah, Zhuoer Xie, et al.
Leukemia Research|October 22, 2013
A phase I study of decitabine and rapamycin in relapsed/refractory AMLJane L Liesveld, Kristen O'Dwyer, Alison Walker, et al.
The Lancet Regional Health. Europe|April 18, 2025
Paramedic analgesia comparing ketamine and morphine in trauma (PACKMaN): a randomised, double-blind, phase 3 trialMichael A Smyth, Hannah Noordali, Kath Starr, et al.
Oncotarget|March 9, 2018
Polo-like kinase inhibitor volasertib marginally enhances the efficacy of the novel Fc-engineered anti-CD33 antibody BI 836858 in acute myeloid leukemiaBhavani Gopalakrishnan, Carolyn Cheney, Rajeswaran Mani, et al.
Pageof 6